metabolic-associated fatty liver disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Meeting the diagnostic criteria for metabolic dysfunction-associated fatty liver disease (MAFLD) 2 Aged 18–65 years voluntarily provided written informed consent and able to cooperate with: (1)Collection of general demographic data (2)Completion of standardized questionnaires (3)Accurate documentation of symptom profiles (4)Provision of complete and reliable medical records
Exclusion criteria
Exclusion criteria: (1)Patients with severe heart lung liver or kidney failure or advanced-stage malignancies (2)Alcohol-related fatty liver disease or mixed-type fatty liver disease (3)Acute hepatitis severe hepatitis decompensated cirrhosis or hepatocellular carcinoma (HCC) (4)Patients with specific diseases that may cause fatty liver including: Viral hepatitis Drug-induced liver injury Total parenteral nutrition (TPN)-associated steatosis Wilsons disease Autoimmune liver diseases Pregnant or lactating women those planning pregnancy in the near future individuals using estrogen-based contraceptives or patients with psychiatric disorders
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| waist circumference;Body weight;Height;Alcohol and Tobacco Use History;urea nitrogen;Urinary albumin creatinine ratio;Complete Blood Count + C-Reactive Protein (CRP);comorbidity;uric acid;Information from TCM's Four Diagnostic Techniques;estimated glomerular filtration rate;Age;Gender;Body mass index;Blood creatinine;blood presure;Medical history; | — |
Primary
| Measure | Time frame |
|---|---|
| NAFLD Fibrosis Score;total protein;glycosylated hemoglobin;Aspartate Aminotransferase;Fibrosis-4 Index;Homeostasis Model Assessment of Insulin Resistance;Fasting blood glucose;total bilirubin;albumin;Alanine Aminotransferase;Serum lipids;Fasting insulin; | — |
Countries
China
Contacts
People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine